Project

Foreign Companies

Project Name A European project on cytotherapy

Country/Region

Britain

Industry

Biotechnology

Investment Mode

Joint Venture

Brief Introduction

The company was founded in 2009. It is a bio pharmaceutical company which aims to develop regenerative medicine. The company has developed four kinds of its own products which are conducting clinical trials. The main product Heartcel has been completed the PIIa clinical trial for late-stage heart failure.

Investment

To be Discussed

Contact

Wang Guyu 18912357105 wittc@wittc.cn

 

The company was founded in 2009. It is a bio pharmaceutical company which aims to develop regenerative medicine. The company has developed four kinds of its own products which are conducting clinical trials. The main product Heartcel has been completed the PIIa clinical trial for late-stage heart failure. 

This company hopes to find investors in China.